Power Corp Of Canada Abb Vie Inc. Transaction History

Power Corp Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 18, 2022	BUY	$134.21 - $153.93 $2.02 Million - $2.31 Million	15,031 New	15,031 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $866,730 - $1.1 Million	-6,298 Reduced 29.53%	15,031 $2.3 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2.82 Million - $3.49 Million	21,329 New	21,329 $3.46 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

Stay updated on Power Corp Of Canada with notifications on news.